mRNAs coding for A1 and A2 isoforms of translation factor eEF1A demonstrate different half-lives while A1 and A2 proteins are similarly stable in MCF7 cells
Open Access
- 20 September 2013
- journal article
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 29 (5) , 389-394
Abstract
Eukaryotic translation elongation factor 1A (eEF1A) exists as two 98 % homologous isoforms eEF1A1 and eEF1A2 that are tissue/development specific and differentially linked to apoptosis/cancerogenesis. A2 is overexpressed in a number of tumors while unusual expression of A1 is observed in injured muscles. To approach a possible mechanism underlying induced changes in the relative amounts of the isoforms we examined the intrinsic stability of the proteins and their mRNAs in human cancer cells. Aim. To estimate half-life of the isoforms of eEF1A at mRNA and protein level in human cancer cells. Methods. To measure mRNA stability the transcriptional block technique was applied, with subsequent analysis of the mRNA level by qPCR. To determine the protein decay rate the translation was blocked by cycloheximide and changes in the protein level were detected by Western blot. Results. Calculation of the protein stability revealed half-life of 72 for eEF1A1 and 95 hours for eEF1A2. Half-life of EEF1A1 and EEF1A2 mRNAs were 3 and 60 hours respectively. Conclusions. Despite similar protein stability, the isoforms of eEF1A dramatically differ in the half-lives of their mRNAs, suggesting that the mRNA decay mechanism is one of the main regulators of eEF1A1/A2 amount in MCF7 cancer cellsKeywords
This publication has 31 references indexed in Scilit:
- eEF1A2 as a Putative OncogeneAnnals of the New York Academy of Sciences, 2009
- Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patientsMetabolism, 2007
- Translation Elongation Factor eEF1A2 Is Essential for Post-weaning Survival in MiceJournal of Biological Chemistry, 2007
- Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumoursBMC Cancer, 2005
- Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancerNature Genetics, 2002
- Peptide Elongation Factor eEF1A-2/S1 Expression in Cultured Differentiated Myotubes and Its Protective Effect against Caspase- 3-mediated ApoptosisJournal of Biological Chemistry, 2002
- Rapid Up-Regulation of Peptide Elongation Factor EF-1α Protein Levels Is an Immediate Early Event during Oxidative Stress-Induced ApoptosisExperimental Cell Research, 2000
- The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the proteinNucleic Acids Research, 1998
- Apoptosis Rate Can Be Accelerated or Decelerated by Overexpression or Reduction of the Level of Elongation Factor-1αExperimental Cell Research, 1998
- Eukaryotic Translation Elongation Factor 1α: Structure, Expression, Functions, and Possible Role in Aminoacyl-tRNA Channeling1998